Search results
Nurix Therapeutics, With 345% Run, Posts A 'Clear Win' In Leukemia Treatment
Investor's Business Daily· 3 hours agoNurix Therapeutics posted a "clear win" in leukemia treatment on Monday, but the biotech stock gave...
PHOTOS: 6-year-old with leukemia aiming for 100 hikes before end of treatment
Colorado Springs Gazette· 5 days ago6-year-old Bellamy Korn plans to go on 100 hikes before she ends her leukemia treatment next year....
The Taunk family's strong bond and brotherly love is helping them through childhood leukemia battle
CBS News· 7 hours agoA child's cancer diagnosis affects the entire family and those effects can be immense and in various...
Amgen's (AMGN) Blincyto Gets FDA Nod for Consolidation Treatment
Zacks via Yahoo Finance· 9 hours agoAmgen's (AMGN) Blincyto is now approved for the treatment of adult and pediatric patients one month...
Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia
Digital Journal· 10 hours agoActinium is a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies. AML mostly affects cells that aren't fully developed, leaving these cells unable ...
EHA 2024: Brukinsa/Venclexta for CLL/SLL lacks control arm in SEQUOIA trial
Clinical Trials Arena via Yahoo Finance· 7 hours agoCLL and SLL are among the most common haematological malignancies...) inhibitors and B cell lymphoma...
John J. York Teases 'General Hospital' Return After Cancer Treatment
TV Insider· 7 hours agoJohn J. York will make his General Hospital return as Mac Scorpio on Wednesday, June 19, after ...
Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Mustang Bio (NASDAQ:MBIO)
Benzinga· 10 hours agoMB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center to treat...
...POSITIVE PHILADELPHIA CHROMOSOME-NEGATIVE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)...
Morningstar· 3 days ago:AMGN) today announced the U.S. Food and Drug Administration (FDA) has approved BLINCYTO® (blinatumomab) for the treatment of adult and pediatric patients one month or older ...
EHA 2024: Novartis Scemblix takes on all TKIs in head-to-head CML trial
Clinical Trials Arena via Yahoo Finance· 23 hours agoHowever, the need for long-term or indefinite daily therapy has led to new...first-generation TKI...